Antimalarial drug discovery targeting apical membrane antigen 1

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Malaria continues to frustrate humanity's attempts to eradicate this deadly disease. Although gains have been made over the last 15 years, drug resistance to malaria continues to be a major concern. The lack of new antimalarials with novel mechanisms of action continues to challenge the scientific community to find innovative targets to combat this persistent disease. One such target, apical membrane antigen 1 (AMA1), is an essential protein that helps the parasite invade host erythrocytes. Recently, a number of efforts have focused on the druggability of this target, aiming to block the interactions of AMA1 that mediate invasion of host cells. This review covers recent progress in drug discovery targeting this crucial protein-protein interaction in malaria.

Original languageEnglish
Pages (from-to)13-20
Number of pages8
JournalMedChemComm
Volume8
Issue number1
DOIs
Publication statusPublished - 2017

Cite this

@article{18df7ec6c56f4993b40c7038dfef17ba,
title = "Antimalarial drug discovery targeting apical membrane antigen 1",
abstract = "Malaria continues to frustrate humanity's attempts to eradicate this deadly disease. Although gains have been made over the last 15 years, drug resistance to malaria continues to be a major concern. The lack of new antimalarials with novel mechanisms of action continues to challenge the scientific community to find innovative targets to combat this persistent disease. One such target, apical membrane antigen 1 (AMA1), is an essential protein that helps the parasite invade host erythrocytes. Recently, a number of efforts have focused on the druggability of this target, aiming to block the interactions of AMA1 that mediate invasion of host cells. This review covers recent progress in drug discovery targeting this crucial protein-protein interaction in malaria.",
author = "Devine, {Shane M} and MacRaild, {Christopher A} and Norton, {Raymond S} and Scammells, {Peter J}",
year = "2017",
doi = "10.1039/c6md00495d",
language = "English",
volume = "8",
pages = "13--20",
journal = "MedChemComm",
issn = "2040-2503",
publisher = "The Royal Society of Chemistry",
number = "1",

}

Antimalarial drug discovery targeting apical membrane antigen 1. / Devine, Shane M; MacRaild, Christopher A; Norton, Raymond S; Scammells, Peter J.

In: MedChemComm, Vol. 8, No. 1, 2017, p. 13-20.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Antimalarial drug discovery targeting apical membrane antigen 1

AU - Devine, Shane M

AU - MacRaild, Christopher A

AU - Norton, Raymond S

AU - Scammells, Peter J

PY - 2017

Y1 - 2017

N2 - Malaria continues to frustrate humanity's attempts to eradicate this deadly disease. Although gains have been made over the last 15 years, drug resistance to malaria continues to be a major concern. The lack of new antimalarials with novel mechanisms of action continues to challenge the scientific community to find innovative targets to combat this persistent disease. One such target, apical membrane antigen 1 (AMA1), is an essential protein that helps the parasite invade host erythrocytes. Recently, a number of efforts have focused on the druggability of this target, aiming to block the interactions of AMA1 that mediate invasion of host cells. This review covers recent progress in drug discovery targeting this crucial protein-protein interaction in malaria.

AB - Malaria continues to frustrate humanity's attempts to eradicate this deadly disease. Although gains have been made over the last 15 years, drug resistance to malaria continues to be a major concern. The lack of new antimalarials with novel mechanisms of action continues to challenge the scientific community to find innovative targets to combat this persistent disease. One such target, apical membrane antigen 1 (AMA1), is an essential protein that helps the parasite invade host erythrocytes. Recently, a number of efforts have focused on the druggability of this target, aiming to block the interactions of AMA1 that mediate invasion of host cells. This review covers recent progress in drug discovery targeting this crucial protein-protein interaction in malaria.

UR - http://www.scopus.com/inward/record.url?scp=85010780467&partnerID=8YFLogxK

U2 - 10.1039/c6md00495d

DO - 10.1039/c6md00495d

M3 - Review Article

VL - 8

SP - 13

EP - 20

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 1

ER -